Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients (Q33385700)

26 July 2017

Antibiotic treatment of Mycobacterium abscessus lung disease: a retrospective analysis of 65 patients (English)

1 reference

26 July 2017

1 reference

Mycobacterium abscessus

1 reference

9

Won-Jung Koh

1 reference

26 July 2017

2

O Jung Kwon

1 reference

26 July 2017

1

Kyeongman Jeon

1 reference

26 July 2017

Nam Yong Lee

3

1 reference

26 July 2017

Bum-Joon Kim

4

1 reference

26 July 2017

Yoon-Hoh Kook

5

1 reference

26 July 2017

Seung-Heon Lee

6

1 reference

26 July 2017

Young Kil Park

7

1 reference

26 July 2017

Chang Ki Kim

8

1 reference

26 July 2017

language of work or name

English

0 references

publication date

6 August 2009

1 reference

American Journal of Respiratory and Critical Care Medicine

26 July 2017

1 reference

26 July 2017

180

1 reference

26 July 2017

896-902

1 reference

26 July 2017

9

1 reference

An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases

26 July 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Pulmonary disease caused by rapidly growing mycobacteria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Diagnosis and treatment of infections caused by rapidly growing mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Diagnosis and treatment of nontuberculous mycobacterial pulmonary diseases: a Korean perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

A prospective study of neutropenia induced by high doses of beta-lactam antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Clarithromycin resistance to Mycobacterium abscessus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Screening for sterilizing activity of antibiotic combinations in an acid model of rapidly growing mycobacteria during the stationary phase of growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Activities of linezolid against rapidly growing mycobacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Mycobacterium abscessus from respiratory isolates: activities of drug combinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

When and how to treat pulmonary non-tuberculous mycobacterial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Amoebal coculture of "Mycobacterium massiliense" sp. nov. from the sputum of a patient with hemoptoic pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Proportions of Mycobacterium massiliense and Mycobacterium bolletii strains among Korean Mycobacterium chelonae-Mycobacterium abscessus group isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Epidemic of postsurgical infections caused by Mycobacterium massiliense.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Mycobacterium bolletii respiratory infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Polyclonal Mycobacterium avium complex infections in patients with nodular bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

Repeat positive cultures in Mycobacterium intracellulare lung disease after macrolide therapy represent new infections in patients with nodular bronchiectasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200905-0704OC

10.1164/RCCM.200905-0704OC

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference